title: Prolactin-secreting tumors: what's new?
abstract: Prolactinomas are a common cause of reproductive/sexual dysfunction. Once other causes of hyperprolactinemia have been excluded with a careful history and physical examination, routine chemistries, a pregnancy test and a thyroid-stimulating hormone, imaging with magnetic resonance imaging or computed tomography will delineate the size and extent of the tumor. Medical therapy with cabergoline or bromocriptine is the initial treatment of choice. When infertility is the primary indication for treatment, bromocriptine use has an extensive safety experience and is preferred by some clinicians. However, for other indications, cabergoline appears to be more efficacious and better tolerated. Transsphenoidal surgery remains an option, especially for patients with microadenomas, when medical therapy is ineffective or not tolerated.
authors.affiliation: Northwestern University Feinberg School of Medicine, Division of Endocrinology, Metabolism and Molecular Medicine, 303 E. Chicago Avenue, Chicago, IL, USA. molitch@northwestern.edu
authors.forename: Mark E
authors.initials: ME
authors.lastname: Molitch
mesh_terms: D000818:Animals; D018491:Dopamine Agonists / Q000627:therapeutic use; D005260:Female; D006727:Hormone Antagonists / Q000627:therapeutic use; D006801:Humans; D006966:Hyperprolactinemia / Q000097:blood / Q000628:therapy; D010911:Pituitary Neoplasms / Q000097:blood / Q000378:metabolism* / Q000628:therapy; D011247:Pregnancy; D011388:Prolactin / Q000097:blood / Q000378:metabolism*; D015175:Prolactinoma / Q000097:blood / Q000378:metabolism* / Q000628:therapy
chemical_list: D018491:Dopamine Agonists; D006727:Hormone Antagonists; D011388:Prolactin